World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03154229
Date of registration: 12/05/2017
Prospective Registration: Yes
Primary sponsor: University of Florida
Public title: Evaluation of a mHealth Platform for Diarrheal Disease Decision-support
Scientific title: The Evaluation of a mHealth Platform for Diarrheal Disease Decision-support in Hospitals: a Cluster Randomized Controlled Trial
Date of first enrolment: March 11, 2018
Target sample size: 4975
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03154229
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Bangladesh
Contacts
Name:     Eric J Nelson, MD PhD
Address: 
Telephone:
Email:
Affiliation:  University of Florida, USA
Key inclusion & exclusion criteria

Inclusion Criteria:

- Acute uncomplicated diarrhea (less than 7 days with at least 3 loose stools in the
last 24 hours)

- Age greater than or equal to two months.

Exclusion Criteria:

- No diarrhea

- Complicated diarrheal disease (e.g. e.g. sepsis, meningitis, convulsions, electrolyte
imbalance, myocardial infarction, respiratory failure, chronic kidney disease, severe
malnutrition by clinical measures and mid-upper arm circumference (<11.5cm for >= 6 mo
to less than 5 years; <11.0 cm for >= 2mo to <6 mo))



Age minimum: 2 Months
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Diarrhea
Intervention(s)
Other: Smartphone-based decision-support
Other: Paper-based decision-support
Other: Pre-Assessment of practices
Primary Outcome(s)
Use of IV fluid [Time Frame: Intervention is 3 months per hospital]
Secondary Outcome(s)
Use of indicated antibiotics [Time Frame: Intervention is 3 months per hospital]
Use of zinc [Time Frame: Intervention is 3 months per hospital]
Secondary ID(s)
IRB201601762 - N
TW010182 [Pending]
1DP5OD019893
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
National Institutes of Health (NIH)
International Centre for Diarrhoeal Disease Research, Bangladesh
Fogarty International Center of the National Institute of Health
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history